Bioactivity:

Vodobatinib is a novel 3rd generation (3G) TKI effective against wild-type and mutated BCR-ABL1 with limited off-target activity.

CAS nr:

1388803-90-4

Purity:

98%

Molecular Weight:

453,92

SMILES:

CC1=C(C(=CC=C1)Cl)C(=O)NNC(=O)C2=CC(=C(C=C2)C)C#CC3=CC4=CC=CC=C4N=C3

Formula:

C27H20ClN3O2

Pathway:

Angiogenesis,Tyrosine Kinase/Adaptors,Cytoskeletal Signaling

Target:

Bcr-Abl,Bcr-Abl,Bcr-Abl